SCHEMBL1585331

SCHEMBL1585331

O=C(NCCc1ccc(F)c(F)c1)c1cccnc1F

nearest known ligand 0.52

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.52
SMN1; SMN2 Q16637 1/20 0.52
NPC1 O15118 3/20 0.50
KMT2A Q03164 3/20 0.50
MEN1 O00255 2/20 0.50
RAB9A P51151 2/20 0.50
LMNA P02545 2/20 0.48
HTT P42858 1/20 0.48
EGLN1 Q9GZT9 3/20 0.47
MAPT P10636 2/20 0.45
TSHR P16473 1/20 0.45
HSD17B10 Q99714 1/20 0.45
PPARG P37231 2/20 0.44
CNR1 P21554 1/20 0.44
CNR2 P34972 1/20 0.44
NAPRT Q6XQN6 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1585094 0.88 ALDH1A1 (0.50) ALDH1A1SMN1; SMN2NPC1KMT2AMEN1
SCHEMBL20881242 0.88 MEN1 (0.54) ALDH1A1SMN1; SMN2NPC1KMT2AMEN1
SCHEMBL1585229 0.87 PPARG (0.56) KMT2ALMNAPPARG
SCHEMBL30573531 0.87 PPARG (0.56) KMT2ALMNAPPARG
SCHEMBL557803 0.84 RAB9A (0.67) ALDH1A1SMN1; SMN2NPC1KMT2AMEN1
SCHEMBL1585808 0.79 MEN1 (0.49) ALDH1A1SMN1; SMN2NPC1KMT2AMEN1
SCHEMBL1585772 0.77 PDPK1 (0.47) ALDH1A1SMN1; SMN2NPC1RAB9ALMNA
SCHEMBL2751567 0.76 KMT2A (0.55) ALDH1A1SMN1; SMN2NPC1KMT2AMEN1
SCHEMBL1585323 0.74 RAB9A (0.45) ALDH1A1SMN1; SMN2NPC1RAB9ALMNA
SCHEMBL1585174 0.74 POLB (0.64) ALDH1A1SMN1; SMN2KMT2ALMNAEGLN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2485731-A1 HETEROCYCLIC COMPOUNDS USEFUL AS PDK1 INHIBITORS Millennium Pharmaceuticals, Inc. (US) 2012-08-15 EP disclosed
WO-2011044157-A1 HETEROCYCLIC COMPOUNDS USEFUL AS PDK1 INHIBITORS BIOGEN IDEC MA INC. (US) 2011-04-14 WO disclosed